|
Once you know what makes you itch, sneeze, wheeze, or break out in spots, ALK-Abelló can prepare a vaccine for you. With subsidiaries and facilities in 15 countries, ALK-Abelló is a leading producer of allergy vaccination and diagnostic pharmaceuticals and the EpiPen brand of adrenaline for emergency use during severe allergy allergic. Involved in the development of allergy vaccinations since 1923, ALK-Abelló is expanding its products to orally delivered vaccinations as well as subcutaneous (injected) vaccinations. It is developing natural allergens in tablet form to fight grass pollen and house dust mites.
|
| | | Contact Information | |
Address: |
Břge Allé 6-8
DK-2970 Hřrsholm, Denmark
| | Phone: | +45-4574-7576 | | Fax: | +45-4574-8690 |
|
| Financial
Highlights | | Fiscal Year End: | August | | Revenue (2008): | 337.90 M | | Revenue Growth (1 yr): | 3.60% |
|
|
Key People
| | • |
Chairman:
Jřrgen Worning
| | • |
President and CEO:
Jens Bager
| | • |
EVP Finance and Information Technology, and CFO:
Jutta of Rosenburg
|
|
|
